Skip to main content
. 2021 Nov 5;2021(11):CD012565. doi: 10.1002/14651858.CD012565.pub2

2.6. Analysis.

2.6

Comparison 2: Major adverse cardiovascular events (MACE) at maximum follow‐up, Outcome 6: MACE (major cardiovascular events) ‐ Subacute vs non‐acute phase